send link to app

POINT 1 Study Site


4.2 ( 7632 ratings )
健康健美 医疗
开发 Parallel 6, Inc.
自由

"Please Note: This app is only for use by those participating in this study. The POINT 1 Study is a two part pediatric
study of Afrezza inhaled human insulin in pediatric patients with type 1 diabetes mellitus.

The POINT 1 Study App is a tool for for enrolled patients to manage and understand study participation."